VEDAVANI TIRUVEEDHULA: Open Payments
NPI 1760865497 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 34 payments from 9 companies in 2025. Trend: 2023 $1,171 · 2024 $913 · 2025 $675
Food & beverage: $564Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $232 |
| ABBVIE INC. | 9 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $89 |
| Alkermes, Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $16 |
Products named: VRAYLAR, AUSTEDO XR, CAPLYTA, ARISTADA, FANAPT, INGREZZA, Auvelity, ABILIFY MAINTENA.
Industry payments across MA — which companies pay providers there.
